Literature DB >> 14566626

Role of OCT in the diagnosis and follow up of diabetic macular edema.

Giacomo Panozzo1, Elena Gusson, Barbara Parolini, Andrea Mercanti.   

Abstract

The aim is to present, along with a brief literature review, the results of OCT scan in eyes with diabetic macular edema (DME), as well as examples of the utility of OCT for different therapeutic approaches. One-hundred and thirty-six eyes with diabetic retinopathy were analyzed with OCT to explore the different patterns of DME. Some eyes with DME were studied with OCT pre and postoperatively to determine the efficacy of photocoagulation and vitrectomy to restore a normal macular profile. Sixty-eight eyes with a central foveal thickness of 200 mu or more were considered "edematous". Three different patterns of DME were recognized and analyzed: macular thickening, cystoid macular edema and shallow retinal detachment. The change in macular profile and internal retinal structure after laser or surgical treatment are well visible with OCT. OCT contributes in understanding the anatomy of DME and the intraretinal damage and seems to be the technique of choice for the follow-up of macular edema. We think that this tool should always be used in monitoring the effect of therapies in future studies.

Entities:  

Mesh:

Year:  2003        PMID: 14566626     DOI: 10.1076/soph.18.2.74.15854

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  14 in total

1.  Optical coherence tomography of the Ex-PRESS miniature glaucoma implant.

Authors:  F D Verbraak; D M de Bruin; M Sulak; L A M S de Jong; M Aalders; D J Faber; T G van Leeuwen
Journal:  Lasers Med Sci       Date:  2005-04-28       Impact factor: 3.161

2.  New algorithm to analyze optical coherence tomographic images quantitatively.

Authors:  Kohei Ishikawa; Yasuki Ito; Ryuji Mizutani; Masato Kikuchi; Hiroaki Nishihara; Hiroko Terasaki
Journal:  Jpn J Ophthalmol       Date:  2008-07-27       Impact factor: 2.447

3.  The effect of center point shift on the measurement of macular thickness: a spectral domain-optical coherence tomography study.

Authors:  Kyoung Nam Kim; Il Hwan Shin; Jae Yun Sung; Baek Soo Kwak; Hyung Bin Lim; Young Joon Jo; Jung Yeul Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-06       Impact factor: 3.117

4.  Automated detection of clinically significant macular edema by grid scanning optical coherence tomography.

Authors:  Srinivas R Sadda; Ou Tan; Alexander C Walsh; Joel S Schuman; Rohit Varma; David Huang
Journal:  Ophthalmology       Date:  2006-05-02       Impact factor: 12.079

Review 5.  A reference standard for the measurement of macular oedema.

Authors:  K A Goatman
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

Review 6.  IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Authors:  Raffael Liegl; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Early Hum Dev       Date:  2016-09-17       Impact factor: 2.079

7.  Treatment of idiopathic macular hole with silicone oil tamponade.

Authors:  Biljana Ivanovska-Adjievska; Salih Boskurt; Faruk Semiz; Hakan Yuzer; Vesna Dimovska-Jordanova
Journal:  Clin Ophthalmol       Date:  2012-08-06

8.  Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres.

Authors:  Markus Ritter; Julee Elledge; Christian Simader; Gabor G Deak; Thomas Benesch; Barbara A Blodi; Ursula M Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2010-08-30       Impact factor: 4.638

Review 9.  Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.

Authors:  Jeffrey K Luttrull; Giorgio Dorin
Journal:  Curr Diabetes Rev       Date:  2012-07-01

Review 10.  Diabetic retinopathy: an update.

Authors:  Ramandeep Singh; Kim Ramasamy; Chandran Abraham; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.